SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601485-23-000035
Filing Date
2023-05-10
Accepted
2023-05-10 16:13:33
Documents
73
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q angn-20230331.htm   iXBRL 10-Q 1006310
2 EX-31.1 ex311_angn-03312023x10xq.htm EX-31.1 11191
3 EX-31.2 ex312_angn-03312023x10xq.htm EX-31.2 11339
4 EX-32.1 ex321angn-03312023x10xq.htm EX-32.1 6118
5 EX-32.2 ex322_angn-03312023x10xq.htm EX-32.2 6179
  Complete submission text file 0001601485-23-000035.txt   5506308

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT angn-20230331.xsd EX-101.SCH 41676
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT angn-20230331_cal.xml EX-101.CAL 58785
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT angn-20230331_def.xml EX-101.DEF 171996
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT angn-20230331_lab.xml EX-101.LAB 548256
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT angn-20230331_pre.xml EX-101.PRE 343557
67 EXTRACTED XBRL INSTANCE DOCUMENT angn-20230331_htm.xml XML 776565
Mailing Address 7-57 WELLS AVENUE NEWTON MA 02459
Business Address 7-57 WELLS AVENUE NEWTON MA 02459 (857) 336-4001
Angion Biomedica Corp. (Filer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39990 | Film No.: 23906521
SIC: 2834 Pharmaceutical Preparations